ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,090.27
      0.25%
      US Tech 100
      21,038.00
      0.79%
      Dow Jones
      44,642.52
      -0.28%
      Brent Oil
      70.95
      0.00%
      Bitcoin
      100,167.63
      0.24%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. PHAXIAM Therapeutics SA (PHXM) Quote

      PHAXIAM Therapeutics SA

      PHAXIAM Therapeutics SA (PHXM)

      EU
      1.75
      0.00
      (0.00%)
      Closed December 07 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.75
      Bid
      1.706
      Ask
      1.77
      Volume
      8,294
      1.712 Day's Range 1.75
      1.50 52 Week Range 5.00
      Market Cap
      54.232M
      Previous Close
      1.75
      Open
      1.75
      Last Trade
      92
      @
      1.75
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      14,829
      Shares Outstanding
      30,989,584
      Dividend Yield
      -
      PE Ratio
      -2.31
      Earnings Per Share (EPS)
      -0.76
      Revenue
      1.33M
      Net Profit
      -23.49M

      About PHAXIAM Therapeutics SA

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.phaxiam.com
      Headquarters
      Lyon, Rhone, Fra
      Founded
      -
      PHAXIAM Therapeutics SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker PHXM. The last closing price for PHAXIAM Therapeutics was 1.75 €. Over the last year, PHAXIAM Therapeutics shares have traded in a share price range of 1.50 € to 5.00 €.

      PHAXIAM Therapeutics currently has 30,989,584 shares outstanding. The market capitalization of PHAXIAM Therapeutics is 54.23 € million. PHAXIAM Therapeutics has a price to earnings ratio (PE ratio) of -2.31.

      Ask ADVFN Intelligence (AI)

      PHXM Latest News

      More News

      PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024

      PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024 Article 223-16 of general regulation of French...

      December 05 2024
      UK Regulatory

      PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024

      PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024 Article 223-16 du Règlement Général de...

      December 05 2024
      UK Regulatory

      PHAXIAM présente une stratégie de développement ambitieuse pour tirer parti de l'évolution rapide du marché de la phagothérapie

      PHAXIAM présente une stratégie de développement ambitieuse pour tirer parti de l'évolution rapide du marché de la phagothérapie Tenue d’un webinaire le 27 novembre 2024 « Evolving strategic...

      November 27 2024
      UK Regulatory

      PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area

      PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area Webinar being held today "Evolving strategic context for phages...

      November 27 2024
      UK Regulatory

      PHAXIAM a présenté son test IVD Phagogramme et l’actualisation du suivi de sensibilité à ses phages lors du premier « Phagogram Day »

      PHAXIAM a présenté son test IVD Phagogramme et l’actualisation du suivi de sensibilité à ses phages lors du premier « Phagogram Day » PHAXIAM a présenté son test IVD Phagogramme et l’actualisation...

      November 18 2024
      UK Regulatory

      PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day"

      PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day" This event, organized in collaboration with Phage Canada and bringing together...

      November 18 2024
      GlobeNewswire Inc.

      PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day"

      PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first "Phagogram Day" PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility...

      November 18 2024
      UK Regulatory

      PHAXIAM Reports Third-Quarter 2024 Financial Information

      PHAXIAM Reports Third-Quarter 2024 Financial Information Cash and cash equivalents of €5.7 million as of September 30, 2024Execution of clinical strategy as planned, with the GLORIA global Phase...

      November 13 2024
      UK Regulatory

      PHAXIAM publie l’information financière du troisième trimestre 2024

      PHAXIAM publie l’information financière du troisième trimestre 2024 Trésorerie et équivalents de trésorerie de 5,7 M€ au 30 septembre 2024Exécution de la stratégie clinique conforme au plan, avec...

      November 13 2024
      UK Regulatory

      Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2024

      Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2024 Information mensuelle relative au nombre total de droits de vote et...

      November 08 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.159.3751.61.781.572165281.68078789DE
      4-0.018-1.018099547511.7681.851.5186651.65940883DE
      120.1086.577344701581.6422.1451.5148291.75068984DE
      26-1.25-41.6666666667331.5114471.85800673DE
      52-2.8-61.53846153854.5551.585572.3512559DE
      1560.96121.5189873420.7960.353263811.18593307DE
      2600.96121.5189873420.7960.353263811.18593307DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      EBUSEbusco Holding NV
      1.755 €
      (25.25%)
      		5.64M
      SEQUASequana medical NV
      0.85 €
      (24.63%)
      		239.85k
      ALENOEnogia SA
      1.785 €
      (14.79%)
      		84.12k
      ALNOVNovacyt
      0.639 €
      (14.11%)
      		922.72k
      UBIUBISoft Entertainment
      13.32 €
      (13.07%)
      		1.71M
      ATOAtos SE
      0.0026 €
      (-98.54%)
      		1.31B
      ALSPWSpineway
      0.0798 €
      (-21.15%)
      		3.56M
      ALCBICrypto Blockchain Industries
      0.1665 €
      (-19.95%)
      		712.38k
      ALDVIAdvicenne
      1.742 €
      (-19.16%)
      		122.88k
      ALAGOEPango SA
      0.1178 €
      (-16.45%)
      		7.39M
      ATOAtos SE
      0.0026 €
      (-98.54%)
      		1.31B
      BCPBanco Comercial Portugues SA
      0.4397 €
      (-2.96%)
      		73.03M
      ALTDTonner Drones
      0.011 €
      (3.77%)
      		43.43M
      ALCYBCybergun
      0.0001 €
      (0.00%)
      		23.43M
      INGAING Groep NV
      15.044 €
      (-0.88%)
      		8.62M

      Discussion

      View Full Feed
      powerbattles powerbattles 5 minutes ago
      Everyone here knows why I came back. The previous merger didn’t work out in the stockholders’ favor, which is why I left. I’ve returned mainly because I was expecting a new merger. Read the post below for more details on why I returned. Your accusation that I am the promoter is completely baseless a
      AFFU
      Menace212 Menace212 5 minutes ago
      All we need is one deal even if it's minimally substance as long as it futhers the development of the drugs. If that happens and we get current we are off to 02+ as a starter.
      RSPI
      garyhalvo garyhalvo 6 minutes ago
      Targeted-yes
      Mystery- no 
      Disgruntled policy holder- probably 
      iclight iclight 6 minutes ago
      It traded 1.4 millions and there are 1.4 billion available. The only nightmare is owning this POS.
      NWBO
      Monksdream Monksdream 7 minutes ago
      MSTR, apparently he was right, well off the highs
      https://investorshub.advfn.com/uimage/uploads/2024/12/7/rywrhIMG_3759.gif
      MSTR
      crazy horse 0 crazy horse 0 7 minutes ago
      When adrenaline kicks in you do things we pulled a guy out of a third story window we placed two ladders one on each side of the widow. Me and my Lt at the time holding the guy under his armpits guided the man down to the ground he was unconscious and did not make it he weighed around 280 to 300 lb
      winstocksnew winstocksnew 8 minutes ago
      That's what I am talking about!
      Up up and away we go.
      Buy Buy Buy!!!
      ABQQ
      Aero-man Aero-man 9 minutes ago
      Halberd is developing real medical products that address real medical issues. It's a pity that we have a few dumb bastards, jerk-n-hard, squat-ster, and others on this board dominating the board and trying to scare people away.
      HALB
      MC10459 MC10459 10 minutes ago
      All common stock holders.
      BDPTD
      Monksdream Monksdream 10 minutes ago
      ADMA, off the 52 week high
      https://investorshub.advfn.com/uimage/uploads/2024/12/7/nzesdIMG_3758.gif
      ADMA
      Bobbar Bobbar 10 minutes ago
      It really could

      Alot of long term shareholders and alot if shareholders that bought at higher PPS


      If its going to go big alot of people are holding for that
      UATG
      Hopeforthefuture3 Hopeforthefuture3 10 minutes ago
      Atl, that's too bad, I always find it prudent portfolio strategy to offset taxable gains with taxable losses. As I have gains in other stocks I find it to my advantage to take the loss in nwbo. The way I did it this year - buying shares 30+ days before selling for a loss- puts me at no risk of missi
      NWBO
      rogers711 rogers711 11 minutes ago
      Means nothing if you don't know the relationship... is it mutual? Or is radiogel paying to use their ppl? 
      RDGL
      tapioca tapioca 11 minutes ago
      They lost credibility a long time ago, and never believe a word that comes out of a pinky CEO’s mouth. And they could care less about shareholders base. That being said I’ve added to the few leftover shares I had in the first run, so I’m obviously hoping for the best here, but my experience in sub p
      HMBL
      nowwhat2 nowwhat2 11 minutes ago
      Yeah but - It doesn't exactly appear to be likely that
      Would need for Bitcoin to reclaim 100,000
      Which, thankfully yes, appears at least somwhat possible

      https://investorshub.advfn.com/uimage/uploads/2024/12/7/jevbhSOLUSD_121212_7_Q.jpg
      SOLUSD
      ilovetech ilovetech 12 minutes ago
      Would be GREAT!
      NWBO
      newmedman newmedman 12 minutes ago
      cdn.bsky.app/img/feed_thumbnail/plain/did:plc:uo2fna47c4v6zcnklxfhcvjb/bafkreiaka3a235zaq7lu77lfatlrwpooygv5gxnktfsxljtu54x6pkr3ly@jpeg
      GolfnutBoston GolfnutBoston 12 minutes ago
      Risk, you've mentioned previously you never read the financials and you have trust in other people's opinions to help you make investment decisions here. You said you don't dabble much in OTC and don't know much about some games that go on, especially in the Pinksheets. Friendly advice is make this
      AFFU
      crazy horse 0 crazy horse 0 15 minutes ago
      yes

      You worked with both guys?
      Budman33 Budman33 15 minutes ago
      Companies have news releases on their schedule nothing appropriate or required to report monthly. That's what quarterly's are for.
      VDRM
      koolmc koolmc 17 minutes ago
      yep first acquisition first, then update on the share retirement imo
      ICTY
      SSKILLZ1 SSKILLZ1 18 minutes ago
      I have to be honest I don't love the two initial signings by the gm this offseason, but don't strongly dislike them either, wouldn't of been my choices, but I can see the path to them working out if you have reasonable expectations. Holmes was fine as reliever as long as he wasn't closing which he w
      Lime Time Lime Time 18 minutes ago
      No flip here. I expect it to keep going up. The markets have changed to bullish. Watch.
      GVSI
      SilkRoad SilkRoad 19 minutes ago
      Just because something hasn’t been announced yet doesn’t mean it isn’t or won’t be. Even you should know that Mr. Web. Could I interest you in something tactical? A new tie or suit perhaps?

      https://www.youtube.com/watch?v=km7DDDE-i0c
      KBLB
      bigsur25 bigsur25 19 minutes ago
      Big meeting in Simi Valley at the Ronald Reagan library big defense meeting maybe MONI has someone there .
      MONI

      Your Recent History

      EU
      PHXM
      PHAXIAM Therapeutics
      Delayed Upgrade Clock